Werewolf Therapeutics (HOWL) Institutional Ownership

$4.87
+0.02 (+0.41%)
(As of 11:00 AM ET)

Institutional Ownership Changes (13F Filings) for Werewolf Therapeutics (NASDAQ:HOWL)

Current
Institutional Ownership
Percentage
64.84%
Number of
Institutional Buyers
(last 12 months)
7
Total
Institutional Inflows
(last 12 months)
$5.95M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$166.40K
Get HOWL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Werewolf Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

HOWL Institutional Buying and Selling by Quarter

Werewolf Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/10/2024 Acadian Asset Management LLC172,883$1.12M0.0%+119.8%0.399%
5/10/2024 Vanguard Group Inc.1,107,347$7.18M0.0%+26.8%2.554%
5/9/2024 HBK Sorce Advisory LLC13,227$86K0.0%-50.0%0.031%
4/19/2024 Denali Advisors LLC26,600$172K0.1%N/A0.061%
2/15/2024 PFM Health Sciences LP3,468,177$13.39M0.8%+35.6%8.529%
2/14/2024 Lighthouse Investment Partners LLC22,472$87K0.0%N/A0.055%
2/5/2024Certuity LLC10,000$39K0.0%N/A0.028%
2/1/2024 Financial Perspectives Inc6,750$26K0.0%+80.0%0.019%
8/4/2023 HBK Sorce Advisory LLC26,454$81K0.0%-50.0%0.074%
5/15/2023 Rubric Capital Management LP1,935,357$5.03M0.1%+5.4%5.449%
5/8/2023 Bailard Inc.18,127$47K0.0%N/A0.051%
2/9/2023 Chicago Partners Investment Group LLC10,729$41K0.0%N/A0.035%
11/15/2022 PFM Health Sciences LP2,815,654$12.70M0.5%+62.7%9.158%
11/15/2022 Platinum Investment Management Ltd.109,530$494K0.0%-48.7%0.356%
11/15/2022Laurion Capital Management LP522,900$2.36M0.0%-2.3%1.700%
11/14/2022Ergoteles LLC114,595$517K0.0%-11.2%0.388%
11/14/2022 Rubric Capital Management LP966,879$4.36M0.2%+371.7%3.274%
10/25/2022 Denali Advisors LLC5,900$27K0.0%N/A0.020%
8/15/2022Laurion Capital Management LP535,160$2.19M0.0%N/A1.935%
8/8/2022 Y Intercept Hong Kong Ltd11,124$45K0.0%N/A0.040%
7/27/2022 Bailard Inc.21,200$87K0.0%N/A0.077%
5/11/2022Granite Point Capital Management L.P.55,000$242K0.1%+266.7%0.199%
2/15/2022Adage Capital Partners GP L.L.C.960,448$11.44M0.0%-2.5%3.483%
2/14/2022Deerfield Management Company L.P. Series C958,125$11.41M0.2%-45.3%3.474%
2/14/2022Soleus Capital Management L.P.64,585$769K0.1%-88.5%0.234%
2/11/2022Granite Point Capital Management L.P.15,000$179K0.0%N/A0.054%
2/8/2022 Northern Trust Corp200,065$2.38M0.0%+184.2%0.725%
11/15/2021Deerfield Management Company L.P. Series C1,752,787$30.08M0.6%-31.3%6.358%
11/15/2021Sphera Funds Management LTD.688,475$11.81M1.0%-2.5%2.497%
11/15/2021 Caas Capital Management LP162,599$2.79M0.1%+62.6%0.590%
11/12/2021 Geode Capital Management LLC136,472$2.34M0.0%+26.2%0.495%
11/10/2021Levin Capital Strategies L.P.15,000$257K0.0%N/A0.054%
11/9/2021 BlackRock Inc.369,961$6.35M0.0%+1.1%1.342%
11/9/2021 Platinum Investment Management Ltd.213,381$3.66M0.1%+3.1%0.774%
11/8/2021 Russell Investments Group Ltd.125,873$2.16M0.0%N/A0.457%
11/2/2021 New York State Common Retirement Fund14,765$253K0.0%+13.3%0.054%
8/23/2021DC Funds LP589,102$10.27M48.8%N/A2.137%
8/17/2021Sphera Funds Management LTD.706,294$12.05M0.8%N/A2.562%
8/17/2021 PFM Health Sciences LP400,000$6.98M0.2%N/A1.451%
8/17/2021Aristides Capital LLC25,585$446K0.1%N/A0.093%
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad)

Nanoviricides Technology Will Transform The Way Viruses & Their Variants Are Treated Worldwide And This Company Is At The Forefront!

See how with its ongoing expansion and development
8/17/2021 Caas Capital Management LP100,000$1.74M0.0%N/A0.363%
8/16/2021California State Teachers Retirement System10,465$183K0.0%N/A0.038%
8/16/2021RA Capital Management L.P.4,291,881$74.85M1.2%N/A15.568%
8/16/2021Alyeska Investment Group L.P.206,201$3.60M0.0%N/A0.748%
8/16/2021Schonfeld Strategic Advisors LLC11,300$197K0.0%N/A0.041%
8/16/2021 Charles Schwab Investment Management Inc.16,038$280K0.0%N/A0.058%
8/16/2021State Street Corp78,237$1.36M0.0%N/A0.284%
8/16/2021 Nuveen Asset Management LLC12,001$209K0.0%N/A0.044%
8/16/2021Goldman Sachs Group Inc.37,435$653K0.0%N/A0.136%
8/13/2021 Northern Trust Corp75,774$1.32M0.0%N/A0.275%
8/13/2021 Geode Capital Management LLC108,178$1.89M0.0%N/A0.392%
8/13/2021MPM Asset Management LLC4,284,172$74.72M13.9%N/A15.540%
8/13/2021 Vanguard Group Inc.173,127$3.02M0.0%N/A0.628%
8/13/2021MPM Oncology Impact Management LP2,388,011$41.65M6.8%N/A8.662%
8/13/2021 FMR LLC315,000$5.49M0.0%N/A1.143%
8/12/2021 JPMorgan Chase & Co.9,352$163K0.0%N/A0.034%
8/11/2021 Arena Capital Advisors LLC CA14,958$261K0.0%N/A0.054%
8/11/2021 Bank of New York Mellon Corp22,213$387K0.0%N/A0.081%
8/11/2021 BlackRock Inc.365,863$6.38M0.0%N/A1.327%
8/11/2021Deutsche Bank AG4,492$78K0.0%N/A0.016%
8/10/2021 Nicholas Investment Partners LP294,654$5.14M0.3%N/A1.069%
8/10/2021 Citigroup Inc.2,016$35K0.0%N/A0.007%
8/4/2021 Migdal Insurance & Financial Holdings Ltd.187,500$3.27M0.0%N/A0.680%
(Data available from 1/1/2016 forward)

HOWL Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of HOWL shares?

During the previous two years, 16 institutional investors and hedge funds held shares of Werewolf Therapeutics. The most heavily invested institutionals were PFM Health Sciences LP ($13.39M), Janus Henderson Group PLC ($10.92M), Vanguard Group Inc. ($7.18M), Rubric Capital Management LP ($5.03M), Laurion Capital Management LP ($2.36M), Acadian Asset Management LLC ($1.12M), and Ergoteles LLC ($517K).Learn more on HOWL's institutional investors.

What percentage of Werewolf Therapeutics stock is owned by institutional investors?

64.84% of Werewolf Therapeutics stock is owned by institutional investors. Learn more on HOWL's institutional investor holdings.

Which institutional investors have been buying Werewolf Therapeutics stock?

Of the 13 institutional investors that purchased Werewolf Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: PFM Health Sciences LP ($1.99M), Janus Henderson Group PLC ($1.69M), Rubric Capital Management LP ($861.85K), Laurion Capital Management LP ($535.16K), Vanguard Group Inc. ($233.91K), Acadian Asset Management LLC ($94.21K), and Bailard Inc. ($39.33K).

How much institutional buying is happening at Werewolf Therapeutics?

Institutional investors have bought a total of 5,537,166 shares in the last 24 months. This purchase volume represents approximately $27.89M in transactions.

Which Werewolf Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Werewolf Therapeutics stock in the last 24 months: Platinum Investment Management Ltd. ($103.85K), HBK Sorce Advisory LLC ($39.68K), Ergoteles LLC ($14.41K), and Laurion Capital Management LP ($12.26K).

How much institutional selling is happening at Werewolf Therapeutics?

Institutional investors have sold a total of 170,197 shares in the last 24 months. This volume of shares sold represents approximately $755.02K in transactions.


This page (NASDAQ:HOWL) was last updated on 5/16/2024 by MarketBeat.com Staff

From Our Partners